Henry Schein Inc (WBO:HSIC)
€ 64.3 0.76 (1.2%) Market Cap: 7.85 Bil Enterprise Value: 10.51 Bil PE Ratio: 27.87 PB Ratio: 2.43 GF Score: 81/100

Henry Schein Inc at UBS Global Healthcare Conference Transcript

May 20, 2019 / 01:00PM GMT
Release Date Price: €60.67 (-0.25%)
Kevin Caliendo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare IT and Distribution

I guess we're ready to roll. Hi, I'm Kevin Caliendo, the health care supply chain analyst here at UBS. And we are very happy and proud to have Stanley Bergman and Steve Palodino, CEO and CFO of Henry Schein with us today.

So Stanley, I don't know if you want to say a couple of words about the company and the markets before we start off on Q&A.

Stanley M. Bergman
Henry Schein, Inc. - Executive Chairman & CEO

Sure, Kevin. I'll be very high level because I think the Q&A is more important than anything I'd say.

So Henry Schein is the largest provider of products and related services to office space dentists, of course, and to physicians outside of the hospital, outside of the nursing home and the drugstore. Our focus is to help practitioners operate a more efficient practice, so that there practitioners can provide great clinical care. And we do everything to help the practitioners achieve that goal.

We have 3

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot